Plain-English translation of NCT06707233 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a treatment called yttrium-90 selective internal radiation therapy (or Y-90 SIRT) for people with liver cancer tumors larger than 7 centimeters that cannot be surgically removed. The treatment delivers radiation directly into the blood vessels that feed the tumor. The study will track how well the treatment works and what side effects people experience.
Many patients with large liver cancers are not candidates for surgery because of the size or location of their tumors. This trial is testing whether this specialized radiation treatment can help shrink these tumors and give patients more time without their cancer growing.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive the radiation treatment as an outpatient procedure. Before treatment, you will have imaging tests to make sure the treatment can be done safely. The study will follow you over time with regular appointments and imaging scans to measure how your tumor responds to treatment and to monitor for any side effects.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China